Key Factor Supporting Global Oral Solid Dosage Contract Manufacturing Market Development in 2025: Increasing Demand For Generic Drugs Fuels Growth In The Oral Solid Dosage Contract Manufacturing Market

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Oral Solid Dosage Contract Manufacturing Market Size By 2025?
The contract manufacturing sector for oral solid dosage forms has experienced considerable recent expansion, projected to increase its valuation from $39.39 billion in 2024 to $42.39 billion the following year, reflecting a 7.6% compound annual growth rate. This upward trajectory observed during the past period stems from factors such as the expanding worldwide population, the increasing incidence of long-term illnesses, and heightened emphasis on innovative research and development efforts.

How Big Is the Oral Solid Dosage Contract Manufacturing Market Size Expected to Grow by 2029?
Anticipation is high for substantial expansion within the contract manufacturing sector for oral solid dosage forms in the forthcoming period, projecting a market valuation of $55.81 billion by 2029, driven by a compound annual growth rate (CAGR) of 7.1%, a trajectory fueled by escalating outsourcing practices among pharmaceutical enterprises, innovations in medication delivery systems, and a rising tempo of drug development endeavors; key developments anticipated to shape this market include progress in drug delivery methods, the incorporation of three-dimensional printing techniques, and improvements in technologies designed for controlled release of therapeutics.

View the full report here:
https://www.thebusinessresearchcompany.com/report/oral-solid-dosage-contract-manufacturing-global-market-report

Which Key Market Drivers Powering Oral Solid Dosage Contract Manufacturing Market Expansion and Growth?
Anticipated escalation in the need for non-proprietary pharmaceuticals forecasts a boost for the oral solid dosage contract manufacturing sector moving ahead. These non-proprietary medications possess equivalent efficacy, potency, safety profile, performance standards, excellent quality, and functional purpose when compared to their originator branded counterparts. Factors such as the cessation of exclusivity periods for patented medicines, initiatives aimed at controlling healthcare expenses, governmental encouragement, and broadened availability of medical services contribute to this surge in generic drug uptake. Contract manufacturing for oral solid dosages substantially supports the creation and supply chain of these generics; contract organizations contribute expertise to boost operational smoothness, lower expenditure, guarantee superior manufacturing standards, and expedite product launches with greater impact. For illustration, data from the United States' federal regulatory body, the Food and Drug Administration, revealed in 2022 that non-proprietary drugs accounted for an estimated 91 percent of dispensed prescriptions across the US, supported by the FDA's approval of over 32,000 such substances, thus confirming that the appetite for generics is the primary impetus behind the expansion of the oral solid dosage contract manufacturing industry.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16137&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Oral Solid Dosage Contract Manufacturing Market?
Leading firms within the oral solid dosage contract manufacturing sector are prioritizing the creation of novel approaches, exemplified by the implementation of continuous manufacturing setups, as a strategy to maintain their competitive edge. Continuous manufacturing lines designate production installations or frameworks employing ongoing processes for fabricating medicinal compounds or related items. Illustratively, in the month of January in 2023, WuXi STA, a pharmaceutical entity based in China, initiated operation of its inaugural continuous manufacturing line specifically designed for oral solid pharmaceutical goods. This state-of-the-art installation represents a notable progression in pharmaceutical fabrication, harnessing the tenets of continuous production to boost the effectiveness, standard, and adaptability inherent in drug manufacturing workflows. This increased responsiveness shortens production schedules and minimizes periods of inactivity, consequently speeding up the conveyance of crucial medicines to those needing them.

What Are the Emerging Segments in the Oral Solid Dosage Contract Manufacturing Market?
The oral solid dosage contract manufacturingmarket covered in this report is segmented -

1) By Product Type: Tablets; Capsules; Powders; Granules; Other Product Types
2) By Service: Drug Product Development; Fill Finish Product Manufacturing; API Manufacturing; Packaging And Labelling; Other Applications
3) By Therapeutic Area: Oncology; Cardiovascular Diseases; Metabolic Disorders; Neurological Disorders; infectious Diseases; Gastrointestinal Diseases; Other Therapeutic Areas
4) By End User: Large Size Companies; Medium And Small Size Companies

Subsegments:
1) By Tablets: Compressed Tablets; Effervescent Tablets; Chewable Tablets; Coated Tablets (Enteric, Film Coated); Sustained Or Controlled Release Tablets
2) By Capsules: Hard Gelatin Capsules; Soft Gel Capsules; Vegetarian Capsules; Liquid-Filled Capsules; Delayed Release Capsules
3) By Powders: Powders For Oral Suspension; Powders For Direct Compression; Powders For Mixing Or Blending; Instant Dissolving Powders
4) By Granules: Granules For Direct Compression; Granules For Tabletting; Effervescent Granules; Delayed Or Controlled Release Granules
5) By Other Product Types: Lozenges; Oral Strips; Oral Thin Films; Effervescent Tablets Or Granules

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16137&type=smp

Who Are the Global Leaders in the Oral Solid Dosage Contract Manufacturing Market?
Major companies operating in the oral solid dosage contract manufacturing market are Pfizer Inc., Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Amgen Inc., Merck KGaA, Siemens Healthineers AG, Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Lonza Group AG, Catalent Inc., Patheon Pharma Services, Fareva Holding SA, Piramal Enterprises Limited, Hetero Drugs Limited, Siegfried Holding AG, Recipharm AB, Almac Group Limited, Aenova Holding GmbH, Jubilant Pharmova Limited, Cambrex Corporation, International Chemical Investors Group (ICIG) operates under the CordenPharma brand, Ajinomoto Co. Inc., Hovione Holding Ltd., Alcami Corporation

Which are the Top Profitable Regional Markets for the Oral Solid Dosage Contract Manufacturing Industry?
Asia-Pacific was the largest region in the oral solid dosage contract manufacturing market in 2024. The regions covered in the oral solid dosage contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16137

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.